Allspring Global Investments Holdings, LLC Alector, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$5.69 - $8.08 $37,975 - $53,925	6,674 New	6,674 $40,000
Q1 2023 Apr 13, 2023	SELL	$5.85 - $9.84 $16,362 - $27,522	-2,797 Reduced 13.58%	17,805 $110,000
Q4 2022 Jan 23, 2023	SELL	$6.88 - $9.55 $2,449 - $3,399	-356 Reduced 1.7%	20,602 $0
Q3 2022 Oct 26, 2022	SELL	$8.19 - $13.2 $17,059 - $27,495	-2,083 Reduced 9.04%	20,958 $198,000
Q2 2022 Jul 25, 2022	SELL	$7.65 - $14.24 $305,288 - $568,275	-39,907 Reduced 63.4%	23,041 $234,000
Q1 2022 May 02, 2022	SELL	$13.02 - $20.78 $3.05 Million - $4.86 Million	-233,940 Reduced 78.8%	62,948 $897,000
Q4 2021 Jan 28, 2022	BUY	$19.35 - $25.54 $5.74 Million - $7.58 Million	296,888 New	296,888 $6.13 Million

Others Institutions Holding ALEC

# of Institutions

165

Shares Held

58.1M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $381M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account